Abstract
Hepatocellular uptake index (HUI) is a quantitative indicator of excretory liver function, which is obtained from signal intensity of the liver and spleen and liver volume on gadoxetate disodium-enhanced MR images. HUI correlates well with existing quantitative liver function test results, such as indocyanine green clearance, and allows segmental liver function to be evaluated even if there are regional differences in liver function.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Seyama Y, Kokudo N (2009) Assessment of liver function for safe hepatic resection. Hepatol Res 39:107–116
Sakka SG (2007) Assessing liver function. Curr Opin Crit Care 13:207–214
Hagiwara M, Rusinek H, Lee VS et al (2008) Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging—initial experience. Radiology 246:926–934
Reimer P, Schneider G, Schima W (2004) Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 14:559–578
Weinmann HJ, Brasch RC, Press WR et al (1984) Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR 142:619–624
Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232
Miyazaki S, Murase K, Yoshikawa T et al (2008) A quantitative method for estimating hepatic blood flow using a dual-input single-compartment model. Br J Radiol 81:790–800
Wehrli FW, MacFall JR, Glover GH et al (1984) The dependence of nuclear magnetic resonance (NMR) image contrast on intrinsic and pulse sequence timing parameters. Magn Reson Imaging 2:3–16
Mørkenborg J, Pedersen M, Jensen FT et al (2003) Quantitative assessment of Gd-DTPA contrast agent from signal enhancement: an in-vitro study. Magn Reson Imaging 21:637–643
Sourbron S, Sommer WH, Reiser MF et al (2012) Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging. Radiology 263:874–883
Tofts PS (2010) T1-weighted DCE imaging concepts: modelling, acquisition and analysis. MAGNETOM Flash 45:30–39
Jarnagin WR, Schwartz LH, Gultekin DH et al (2009) Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol 20:1589–1595
Schuhmann-Giampieri G (1993) Nonlinear pharmacokinetic modeling of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging. Arzneimittelforschung 43:1020–1024
Kim T, Murakami T, Hasuike Y et al (1997) Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA. J Magn Reson Imaging 7:683–688
Shimizu J, Dono K, Gotoh M et al (1999) Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging. Dig Dis Sci 44:1330–1337
Yamada A, Hara T, Li F et al (2010) Evaluation of liver function using gadoxetate disodium (Gd-EOB-DTPA) enhanced MR imaging. In: Molthen RC, Weaver JB (eds) Proc. SPIE 7626, Medical Imaging 2010: Biomedical Applications in Molecular, Structural, and Functional Imaging, San Diego, California, pp 762604–762610 (March 4, 2010) doi: 10.1117/12.843722
Motosugi U, Ichikawa T, Sou H et al (2009) Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging 30:1042–1046
Kötz B, West C, Saleem A et al (2009) Blood flow and Vd(water): both biomarkers required for interpreting the effects of vascular targeting agents on tumor and normal tissue. Mol Cancer Ther 8:303–309
Ryeom HK, Kim SH, Kim JY et al (2004) Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Korean J Radiol 5:231–239
Nilsson H, Blomqvist L, Douglas L et al (2010) Assessment of liver fraction in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB 12:567–576
Tsuda N, Okada M, Murakami T (2010) New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI. Eur J Radiol 73:137–142
Motosugi U, Ichikawa T, Tominaga L et al (2009) Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time? Eur Radiol 19:2623–2629
Hashimoto M, Watanabe G (2000) Hepatic parenchymal cell volume and the indocyanine green tolerance test. J Surg Res 92:222–227
Yamada A, Hara T, Li F et al (2011) Quantitative evaluation of liver function with use of gadoxetate disodium–enhanced MR imaging. Radiology 260:727–733
Yamada A, Kadoya M, Ueda K et al (2011) Computerized estimation of quantitative segmental liver reserve after transcatheter arterial chemoembolization by use of gadoxetate. In: RSNA. McCormick Place Convention Center, Chicago. Radiological Society of North America
Yamada A, Hara T, Li F et al (2010) Computerized analysis of liver function using gadoxetate disodium–enhanced MR Imaging. In: RSNA. McCormick Place Convention Center, Chicago. Radiological Society of North America
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yamada, A. (2014). Quantitative Evaluation of Liver Function Within MR Imaging. In: El-Baz, A., Saba, L., Suri, J. (eds) Abdomen and Thoracic Imaging. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-8498-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8498-1_9
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-8497-4
Online ISBN: 978-1-4614-8498-1
eBook Packages: MedicineMedicine (R0)